PREEMPTION EXEMPTION: FDA-APPROVED ABORTION DRUGS AFTER DOBBS

被引：0
|
作者：
Huber, Jared C. [1 ]
机构：
[1] Univ Notre Dame, Law Sch, Notre Dame, IN 46556 USA
来源：
NOTRE DAME LAW REVIEW | 2023年 / 98卷 / 05期
关键词：
D O I：
暂无
中图分类号：
D9 [法律]; DF [法律];
学科分类号：
0301 ;
摘要：
引用
收藏
页码：2217 / 2255
页数：39
相关论文
共 50 条
  • [31] Repurposing FDA-approved drugs for anti-aging therapies
    Snell, Terry W.
    Johnston, Rachel K.
    Srinivasan, Bharath
    Zhou, Hongyi
    Gao, Mu
    Skolnick, Jeffrey
    BIOGERONTOLOGY, 2016, 17 (5-6) : 907 - 920
  • [32] FDA-Approved Fluorinated Heterocyclic Drugs from 2016 to 2022
    Rizzo, Carla
    Amata, Sara
    Pibiri, Ivana
    Pace, Andrea
    Buscemi, Silvestre
    Piccionello, Antonio Palumbo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (09)
  • [33] Identification of FDA-Approved Drugs That Induce Heart Regeneration in Mammals
    Nguyen, Ngoc U.
    Ahmed, Mahmoud S.
    Nakada, Yuji
    Hsu, Ching-Cheng
    Farag, Ayman
    Wang, Ping
    Menendez-Montes, Ivan
    Thet, Suwannee
    Lam, Nicholas T.
    Tomchick, Diana R.
    Walcott, Gregory
    Grishin, Nick V.
    Zhang, Jianyi J.
    Sadek, Hesham A.
    CIRCULATION RESEARCH, 2022, 131 (12) : E171 - E171
  • [34] Identification of FDA-approved drugs that induce heart regeneration in mammals
    Mahmoud Salama Ahmed
    Ngoc Uyen Nhi Nguyen
    Yuji Nakada
    Ching-Cheng Hsu
    Ayman Farag
    Nicholas T. Lam
    Ping Wang
    Suwannee Thet
    Ivan Menendez-Montes
    Waleed M. Elhelaly
    Xi Lou
    Ilaria Secco
    Mateusz Tomczyk
    Lorena Zentilin
    Jimin Pei
    Miao Cui
    Matthieu Dos Santos
    Xiaoye Liu
    Yan Liu
    David Zaha
    Gregory Walcott
    Diana R. Tomchick
    Chao Xing
    Cheng Cheng Zhang
    Nick V. Grishin
    Mauro Giacca
    Jianyi Zhang
    Hesham A. Sadek
    Nature Cardiovascular Research, 2024, 3 : 372 - 388
  • [35] Repackaging FDA-approved drugs for degenerative diseases: promises and challenges
    Cummings, Jeffrey L.
    Zhong, Kate
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2014, 7 (02) : 161 - 165
  • [36] Repurposing of FDA-approved drugs against cancer - focus on metastasis
    Ozsvari, Bela
    Lamb, Rebecca
    Lisanti, Michael P.
    AGING-US, 2016, 8 (04): : 567 - 568
  • [37] Illegitimate companies threaten patients' receipt of FDA-approved drugs
    Thompson, Cheryl A.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2013, 70 (19) : 1646 - 1647
  • [38] Mechanisms of action for FDA-approved drugs targeting breast cancer
    Dhilna, Francis
    Binitha, R. N.
    Riswina, Nissar
    Divya, Sebatain
    Rima, Joseph
    Janish, P. A.
    Subin, Balachandran
    REVISTA DE SENOLOGIA Y PATOLOGIA MAMARIA, 2025, 38 (01):
  • [39] Identification of FDA-approved drugs that induce heart regeneration in mammals
    Ahmed, Mahmoud Salama
    Nguyen, Ngoc Uyen Nhi
    Nakada, Yuji
    Hsu, Ching-Cheng
    Farag, Ayman
    Lam, Nicholas T.
    Wang, Ping
    Thet, Suwannee
    Menendez-Montes, Ivan
    Elhelaly, Waleed M.
    Lou, Xi
    Secco, Ilaria
    Tomczyk, Mateusz
    Zentilin, Lorena
    Pei, Jimin
    Cui, Miao
    Dos Santos, Matthieu
    Liu, Xiaoye
    Liu, Yan
    Zaha, David
    Walcott, Gregory
    Tomchick, Diana R.
    Xing, Chao
    Zhang, Cheng Cheng
    Grishin, Nick V.
    Giacca, Mauro
    Zhang, Jianyi
    Sadek, Hesham A.
    NATURE CARDIOVASCULAR RESEARCH, 2024, 3 (3): : 372 - 388
  • [40] Scientists Repurposing FDA-Approved Drugs to Fight against Viruses
    YAN Fusheng
    Bulletin of the Chinese Academy of Sciences, 2019, 33 (03) : 187 - 188
12345